Blog
694 Articles
Exercise Helps Boost Immune System and Immunotherapy Treatment
Dr. Emma Kurz is part of a research team that has found that exercise can help make immunotherapy more effective for pancreatic cancer.
I Thought it Was a Stomach Bug
Robert Gamble thought he had a stomach bug, but it turned out to be pancreatic cancer. He needed surgery and chemotherapy.
More Effective Radiotherapy for Advanced Pancreatic Cancer Patients
Researchers are testing a drug that penetrates the stroma, to make radiotherapy work better for advanced pancreatic cancer patients.
Newly Discovered Protein Complex in RAS Pathway May Provide a Treatment Target
Dr. Andrew Aguirre and other researchers from Dana-Farber and the Broad Institute are looking at the RAS pathway for a new target.
A Second Opinion Saved My Life!
With encouragement from her husband, Janet McNabb went for a second opinion after a tumor was found on her pancreas.
The Optimist
Roxanne Waling is a long-term survivor of pancreatic cancer, and she credits her integrative oncology team for helping her through.
Diagnosing Pancreatic Cancer: Tests to Expect
Dr. Gobind Anand outlines the tests used to diagnose pancreatic cancer and what to expect if the disease is suspected.
Catching Up With Survivors
How are some of our long-term survivors doing? Roberta Luna, Steven Merlin, Camille Moses, Ed Duncan, and Laurie MacCaskill tell all.
Managing Metastatic Pancreatic Cancer with Chemotherapy and Diet
A new clinical trial looks at a special diet that tries to curb a patient’s metabolism to slow cancer growth during chemotherapy.
Finding the Best Diabetes Drug for Pancreatic Cancer Patients
Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients who develop diabetes.
Family History Matters
After Martin Abrams lost two siblings to pancreatic cancer, he made sure he was screened regularly because of his family history.
Calming the Storm of a Pancreatic Cancer Diagnosis
Social worker Angie Heller and caregiver Richard Cohen describe ways patients and loved ones can focus on what matters most after diagnosis.
Surveillance Improves Outcomes for High-Risk Patients
Dr. Michael Goggins provides results for the CAPS5 pancreatic cancer surveillance and screening study for patients at high risk.
Shedding More Light On Neoadjuvant Treatment
Dr. Matthew Katz reviews the study that compared neoadjuvant treatment with FOLFIRINOX versus gemcitabine/nab-paclitaxel for resectable pancreatic cancer.
Looking Forward to Tomorrow
Earl Groce is a long-term survivor of stage IV pancreatic cancer. He credits the clinical trial he was on with giving him time.